Immunoactive Products of Placenta. V. Immunoregulatory Properties of a Low Molecular Weight Compound Obtained From Human Placental Cultures
- 1 July 1996
- journal article
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 36 (1) , 11-24
- https://doi.org/10.1111/j.1600-0897.1996.tb00134.x
Abstract
PROBLEM: We have previously shown that supernatants from short-term cultures of human placental explants (HPS) are immunosuppressive in vitro as well as in vivo. They contain a low M.W. factor endowed with immunoregulatories activities (Filtrate of such with a 5 kDa cut off). In this paper, we wanted to assess whether this low M.W. material accounts for most, if not all, of the immunosuppressive properties of crude HPS and begin to investigate its mode of action. RESULTS: The filtrate is active across species barrier and inhibits human and murine PHA driven lymphocyte proliferation, Mixed Lymphocyte Reaction, and Natural Killer activity as did crude HPS. It does not affect CTL lytic function at effector stage. Its cross species activity allowed us to study its effects in vivo. It corrects resorbtions in the CBA x DBA/2 murine spontaneous abortion model, and suppresses local and general GVH reactions in a model (A cells into irradiated A x B F1s) relevant to a clinical use, e.g., bone marrow transplantation. To ensure that such survival of the recipients was due to donor cells in the latter, surviving experimental animals were analysed by FACS for repopulating lymphocytes phenotype, which was indeed of donor origin. To elucidate the mechanism(s) of action of the active HPS moiety, we first tested various malignant cell lines for the minimal incubation time required for maximal lymphocyte inhibition. In the same vein, we verified that lymphocytes stimulated by PHA and simultaneously treated with filtrate were unresponsive to a second PHA challenge. The effects of the material was reversible if cells were washed out of it early enough before otherwise entering a cycle leading ultimately to cell death in vitro. Finally, we tested several second messenger pathways, none of which were modified. CONCLUSION: These data suggest that the filtrate contains an entity that represents the main, if not all, the immunosuppressive molecules present in HPS. In addition, they suggest that the material acts only on activated T cells and requires to be present early in the replication activation cycle. Altogether, the in vitro data strongly suggest that the material is acting by inducing clonal deletion in activated (T) cells.Keywords
This publication has 22 references indexed in Scilit:
- Suppression of Local and Systemic GVHR by Supernatants from Human Choriocarcinoma Cell LinesCellular Immunology, 1993
- In vitro and in vivo immunosuppressive effects of supernatants from human choriocarcinoma cell linesCellular Immunology, 1991
- EDITORIAL: HLA G: At the InterfaceAmerican Journal of Reproductive Immunology, 1990
- Immunoactive products of human placenta. II. Direct inhibition of non-MHC restricted cytolytic activity of human CD3 alpha-beta but not CD3 gamma-delta expressing T cell clonesJournal of Reproductive Immunology, 1989
- Calcium and T lymphocyte activationCell, 1989
- Immunoactive products of human placentaCellular Immunology, 1989
- Cyclic AMP‐mediated alteration of the CD2 activation process in human T lymphocytes. Preferential inhibition of the phosphoinositide cycle‐related transduction pathwayEuropean Journal of Immunology, 1988
- Infiltrating decidual natural killer cells are associated with spontaneous abortion in miceCellular Immunology, 1988
- The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune responseImmunology Today, 1988
- IL2-like material is present in human placenta and amnionJournal of Reproductive Immunology, 1987